Ligand Pharmaceuticals (LGND) Gross Profit (2010 - 2019)
Ligand Pharmaceuticals' Gross Profit came in at $21.66 million for Q3 2019, down 51.0% from $44.2 million a year earlier and down 4.1% from the prior quarter.
Powered by 
Analysis
Ligand Pharmaceuticals (LGND) Gross Profit (2010 - 2019) Analysis & Trends
Over the trailing twelve months to Sep 30, 2019, Ligand Pharmaceuticals reported Gross Profit of $140.5 million, down 43.0% year-over-year; for FY2018, it came in at $245.12 million, up 80.6% from FY2017.
- Gross Profit has increased in each of the last seven years, with a five-year compound annual growth rate of 41.5% (FY2013 to FY2018).
- Going back by year, Gross Profit was $135.74 million in FY2017 (+31.3%), $103.4 million in FY2016 (+56.4%), $66.11 million in FY2015 (+19.3%) and $55.4 million in FY2014 (+28.1%).
- The Q3 2019 figure represents the lowest quarterly Gross Profit since Q3 2016.
- Year-over-year, Gross Profit has declined for four consecutive quarters, with an average decline of 11.4% over the last eight quarters.
- The fastest year-over-year change in Gross Profit over five years came in Q2 2017 (growth of 374.1%), and the weakest in Q2 2019 (a decline of 74.6%).
- Business Quant data shows LGND's Gross Profit at $22.58 million (Q2 2019), $39.63 million (Q1 2019) and $56.64 million (Q4 2018) in the three quarters before Q3 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Ligand Pharmaceuticals | 6.22 Bn | 2.69 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2019 | 21.66 Mn |
| Jun 30, 2019 | 22.58 Mn |
| Mar 31, 2019 | 39.63 Mn |
| Dec 31, 2018 | 56.64 Mn |
| Sep 30, 2018 | 44.20 Mn |
| Jun 30, 2018 | 88.91 Mn |
| Mar 31, 2018 | 55.37 Mn |
| Dec 31, 2017 | 57.85 Mn |
| Sep 30, 2017 | 43.28 Mn |
| Jun 30, 2017 | 89.14 Mn |
| Mar 31, 2017 | 55.82 Mn |
| Dec 31, 2016 | 35.29 Mn |
| Sep 30, 2016 | 20.62 Mn |
| Jun 30, 2016 | 18.80 Mn |
| Mar 31, 2016 | 28.69 Mn |
| Dec 31, 2015 | 20.31 Mn |
| Sep 30, 2015 | 16.45 Mn |
| Jun 30, 2015 | 15.82 Mn |
| Mar 31, 2015 | 13.53 Mn |
| Dec 31, 2014 | 19.00 Mn |
API Access
Ligand Pharmaceuticals Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=LGND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "LGND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=LGND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();